314 related articles for article (PubMed ID: 7727766)
41. Homozygous deletions at 9p21 in childhood acute lymphoblastic leukemia detected by microsatellite analysis.
Takeuchi S; Koike M; Seriu T; Bartram CR; Slater J; Park S; Miyoshi I; Koeffler HP
Leukemia; 1997 Oct; 11(10):1636-40. PubMed ID: 9324282
[TBL] [Abstract][Full Text] [Related]
42. Alterations of the p15, p16,and p18 genes in osteosarcoma.
Miller CW; Aslo A; Campbell MJ; Kawamata N; Lampkin BC; Koeffler HP
Cancer Genet Cytogenet; 1996 Feb; 86(2):136-42. PubMed ID: 8603340
[TBL] [Abstract][Full Text] [Related]
43. Establishment of a novel human B-cell line (OZ) with t(14;18)(q32;q21) and aberrant p53 expression was associated with the homozygous deletions of p15INK4B and p16INK4A genes.
Nagai M; Fujita M; Ohmori M; Matsubara S; Taniwaki M; Horiike S; Tasaka T; Koeffler HP; Takahara J
Hematol Oncol; 1997 Aug; 15(3):109-19. PubMed ID: 9600110
[TBL] [Abstract][Full Text] [Related]
44. Loss of chromosome arm 9p DNA and analysis of the p16 and p15 cyclin-dependent kinase inhibitor genes in human parathyroid adenomas.
Tahara H; Smith AP; Gaz RD; Arnold A
J Clin Endocrinol Metab; 1996 Oct; 81(10):3663-7. PubMed ID: 8855819
[TBL] [Abstract][Full Text] [Related]
45. Loss of cyclin-dependent kinase inhibitor genes and chromosome 9 karyotypic abnormalities in human bladder cancer cell lines.
Southgate J; Proffitt J; Roberts P; Smith B; Selby P
Br J Cancer; 1995 Nov; 72(5):1214-8. PubMed ID: 7577470
[TBL] [Abstract][Full Text] [Related]
46. Homozygous codeletion and differential decreased expression of p15INK4b, p16INK4a-alpha and p16INK4a-beta in mouse lung tumor cells.
Herzog CR; Soloff EV; McDoniels AL; Tyson FL; Malkinson AM; Haugen-Strano A; Wiseman RW; Anderson MW; You M
Oncogene; 1996 Nov; 13(9):1885-91. PubMed ID: 8934534
[TBL] [Abstract][Full Text] [Related]
47. The commonly deleted region at 9p21-22 in lymphoblastic leukemias spans at least 400 kb and includes p16 but not p15 or the IFN gene cluster.
Aguiar RC; Sill H; Goldman JM; Cross NC
Leukemia; 1997 Feb; 11(2):233-8. PubMed ID: 9009086
[TBL] [Abstract][Full Text] [Related]
48. Cumulation of TP53 mutations and p16INK4A/p15INK4B homozygous deletions in human papilloma virus type 16 positive scrotal cancer.
Güran S; Pak I
Cancer Genet Cytogenet; 1999 Mar; 109(2):108-13. PubMed ID: 10087941
[TBL] [Abstract][Full Text] [Related]
49. Homozygous deletions of p16INK4A/MTS1 and p15INK4B/MTS2 genes in glioma cells and primary glioma tissues.
Izumoto S; Arita N; Ohnishi T; Hiraga S; Taki T; Hayakawa T
Cancer Lett; 1995 Nov; 97(2):241-7. PubMed ID: 7497469
[TBL] [Abstract][Full Text] [Related]
50. Mutations of p16Ink4/CDKN2 and p15Ink4B/MTS2 genes in biliary tract cancers.
Yoshida S; Todoroki T; Ichikawa Y; Hanai S; Suzuki H; Hori M; Fukao K; Miwa M; Uchida K
Cancer Res; 1995 Jul; 55(13):2756-60. PubMed ID: 7796400
[TBL] [Abstract][Full Text] [Related]
51. Inverse correlation between loss of heterozygosity of the short arm of chromosome 12 and p15ink4B/p16ink4 gene inactivation in childhood acute lymphoblastic leukaemia.
Heyman M; Calero Moreno T; Liu Y; Grandér D; Rasool O; Borgonova-Brandter L; Merup M; Söderhäll S; Einhorn S
Br J Haematol; 1997 Jul; 98(1):147-50. PubMed ID: 9233578
[TBL] [Abstract][Full Text] [Related]
52. Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells.
Drexler HG
Leukemia; 1998 Jun; 12(6):845-59. PubMed ID: 9639410
[TBL] [Abstract][Full Text] [Related]
53. Deletion and altered regulation of p16INK4a and p15INK4b in undifferentiated mouse skin tumors.
Linardopoulos S; Street AJ; Quelle DE; Parry D; Peters G; Sherr CJ; Balmain A
Cancer Res; 1995 Nov; 55(22):5168-72. PubMed ID: 7585567
[TBL] [Abstract][Full Text] [Related]
54. Inhibition of T-cell acute lymphoblastic leukemia proliferation in vivo by re-expression of the p16INK4a tumor suppressor gene.
Schoppmeyer K; Norris PS; Haas M
Neoplasia; 1999 Jun; 1(2):128-37. PubMed ID: 10933047
[TBL] [Abstract][Full Text] [Related]
55. Molecular analysis of cyclin-dependent kinase inhibitors in human leukemias.
Hayette S; Thomas X; Bertrand Y; Tigaud I; Callanan M; Thiebaut A; Charrin C; Archimbaud E; Magaud JP; Rimokh R
Leukemia; 1997 Oct; 11(10):1696-9. PubMed ID: 9324291
[TBL] [Abstract][Full Text] [Related]
56. Mechanisms of inactivation of p14ARF, p15INK4b, and p16INK4a genes in human esophageal squamous cell carcinoma.
Xing EP; Nie Y; Song Y; Yang GY; Cai YC; Wang LD; Yang CS
Clin Cancer Res; 1999 Oct; 5(10):2704-13. PubMed ID: 10537333
[TBL] [Abstract][Full Text] [Related]
57. Genomic alterations of the p19ARF encoding exons in T-cell acute lymphoblastic leukemia.
Gardie B; Cayuela JM; Martini S; Sigaux F
Blood; 1998 Feb; 91(3):1016-20. PubMed ID: 9446664
[TBL] [Abstract][Full Text] [Related]
58. High incidence of allelic loss on chromosome 5 and inactivation of p15INK4B and p16INK4A tumor suppressor genes in oxystress-induced renal cell carcinoma of rats.
Tanaka T; Iwasa Y; Kondo S; Hiai H; Toyokuni S
Oncogene; 1999 Jun; 18(25):3793-7. PubMed ID: 10391689
[TBL] [Abstract][Full Text] [Related]
59. Deletion or lack of expression of CDKN2 (CDK4I/MTS1/INK4A) and MTS2 (INK4B) in acute lymphoblastic leukemia cell lines reflects the phenotype of the uncultured primary leukemia cells.
Jagasia AA; Sher DA; Le Moine PJ; Kim DH; Moldwin RL; Smith SD; Diaz MO
Leukemia; 1996 Apr; 10(4):624-8. PubMed ID: 8618438
[TBL] [Abstract][Full Text] [Related]
60. Exclusive p15INK4B gene deletions in acute lymphocytic leukemia include the E1 beta exon of the p16INK4 gene.
Heyman M; Rasool O; Brandter LB; Liu Y; Grandér D; Einhorn S; Söderhäll S
Blood; 1996 Feb; 87(4):1657-8. PubMed ID: 8608263
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
